# Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

> **NCT06430424** · — · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 40 (estimated)

## Conditions studied

- Relapsed Cancer
- Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

## Interventions

- **BIOLOGICAL:** Relapsed glioblastoma

## Key facts

- **NCT ID:** NCT06430424
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-05
- **Primary completion:** 2025-07
- **Final completion:** 2026-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430424, "Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06430424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*